Regulation (EU) 2022/112 of the European Parliament and of the Council of 25 January 2022 amending Regulation (EU) 2017/746 as regards transitional provisions for certain in vitro diagnostic medical devices and the deferred application of conditions for in-house devices (Text with EEA relevance)
Basic information
Dates Date of document:
  • January 25, 2022
Date of publication:
  • January 28, 2022
Date of effect:
  • January 28, 2022
    • Entry into force - Date pub. See Art 2
Modified by
Modifies
Modifies:
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE XIV - PUBLIC HEALTH Article 168 (ex Article 152 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS CHAPTER 3 - APPROXIMATION OF LAWS Article 114 (ex Article 95 TEC)
EuroVoc Vocabulary
  • Marketing standard
  • Epidemic
  • Public health
  • Single market
  • EC conformity marking
  • Market approval
  • Protection of health and safety
  • Technical barriers
  • Medical diagnosis
  • Medical device
  • Internal market - Principles
  • Coronavirus disease
  • Security of supply
  • Public health